iBio (IBIO) Gross Profit (2020 - 2022)
iBio's (IBIO) quarterly Gross Profit came in at $46000.0 in Q2 2022, down 84.87% year-on-year from $304000.0 in Q2 2021, and down 97.57% on a QoQ basis from $1.9 million in Q1 2022.
iBio (IBIO) Gross Profit (2020 - 2022) Analysis & Trends
iBio (IBIO) has 3 years of Gross Profit data on file, last reported at $46000.0 in Q2 2022.
- On a quarterly basis, Gross Profit fell 84.87% year-over-year to $46000.0 in Q2 2022; TTM through Jun 2022 was $2.2 million, a 57.83% increase from a year earlier, with the FY2022 full-year figure at $2.2 million, up 138.39% from the prior year.
- Gross Profit for Q2 2022 stood at $46000.0, down from $1.9 million in the prior quarter.
- Over the last five years, Gross Profit for IBIO reached as high as $1.9 million in Q1 2022 and fell as low as $10000.0 in Q1 2020.
- Historically, Gross Profit has averaged $437100.0 across 3 years, with a median of $287500.0 in 2020.
- On a YoY basis, Gross Profit climbed as much as 2620.0% in 2021 and fell as far as 88.87% in 2021.
- Year by year, Gross Profit stood at $494000.0 in 2020, then sank by 88.87% to $55000.0 in 2021, then decreased by 16.36% to $46000.0 in 2022.
- Per Business Quant data, the three most recent Gross Profit figures were $46000.0 in Q2 2022, $1.9 million in Q1 2022, and $55000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 46,000.00 |
| Jun 30, 2022 | 46,000.00 |
| Mar 31, 2022 | 1.90 Mn |
| Mar 31, 2022 | 1.90 Mn |
| Dec 31, 2021 | 55,000.00 |
| Dec 31, 2021 | 55,000.00 |
| Sep 30, 2021 | 171,000.00 |
| Sep 30, 2021 | 171,000.00 |
| Jun 30, 2021 | 304,000.00 |
| Jun 30, 2021 | 304,000.00 |
| Mar 31, 2021 | 272,000.00 |
| Mar 31, 2021 | 272,000.00 |
| Dec 31, 2020 | 494,000.00 |
| Dec 31, 2020 | 494,000.00 |
| Sep 30, 2020 | 303,000.00 |
| Sep 30, 2020 | 303,000.00 |
| Jun 30, 2020 | 821,000.00 |
| Jun 30, 2020 | 821,000.00 |
| Mar 31, 2020 | 10,000.00 |
| Mar 31, 2020 | 10,000.00 |